Until Wednesday, people with idiopathic pulmonary fibrosis (IPF) had limited treatment options. Treatment options for this chronic lung condition expanded when the US Food and Drug Administration (FDA) approved two separate medications to treat IPF.

Idiopathic pulmonary fibrosis is a condition for which the cause is not known. Seeing how far a person can walk in six minutes may help doctors and patients understand the condition better.

Pulmonary fibrosis can lead to shortness of breath and a decreased ability to exercise. A recent study looked at how rehabilitation affects measures of exercise ability.

Cholesterol-reducing drugs have been shown to be quite effective in helping treat other disorders. Unfortunately, it may increase the risk of developing interstitial lung disease ( ILD ).

Sudden coughing attacks for patients with Chronic Obstructive Pulmonary Disease (COPD) can be a frightening, life-threatening event. These are usually brought on by bacterial infections.

Sometimes, treating one disease can help patients deal with another. This seems to be the case for patients with a certain lung disease who are also being treated for acid reflux disease.